In the present study, the majority of the patients with colon cancer exhibited low levels of COX-2 expression in the tumor tissues and high levels of COX-2 expression in the adjacent normal tissues, as determined by western blotting and IHC staining. The gene discussed is PTGS2; the disease is colonic neoplasm.